Private Equity Group Gets Control of Campbell-Based Saama Technologies in $430M Deal
Pharma Venture Funds See Value in Saama’s Leadership
The Silicon Valley Business Journal reports that investors led by The Carlyle Group have bought a majority stake in Campbell health tech company Saama Technologies Inc.
Cromwell Schubarth, TechFlash Editor, writes that “Saama said that the deal announced on Wednesday will help it expand its marketing and sales capabilities and help it further investing in AI research and development.”
Access Out-of-the-Box Features in 4 Weeks—Guaranteed.
Saama can put you on the fast track to clinical trial process innovation.